Outlook Therapeutics, Inc.

NASDAQ:OTLK

Biotechnology

Healthcare
$0.40 -5.76%

-$0.10 today

Market cap
$97.62M
Beta
0.98
P/E (TTM)
-2.1
EPS (TTM)
-$0.74
52W Low $0.16High $3.39

Volume 6.81M

Average 17.46M

Price history

Outlook Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-78.67%

Period high

$2.47

Period low

$0.20

Latest

$0.40

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13GOct 13, 2026Oct 13, 2026
8-KSep 30, 2026Sep 30, 2026
8-KSep 18, 2026Sep 18, 2026
4Sep 2, 2026Sep 2, 2026
3Sep 2, 2026Sep 2, 2026
8-KAug 27, 2026Aug 27, 2026
SC 13GAug 19, 2026Aug 19, 2026
10-QAug 18, 2026Aug 18, 2026
NT 10-QAug 17, 2026Aug 17, 2026
8-KAug 14, 2026Aug 14, 2026
4Aug 14, 2026Aug 14, 2026
4Aug 14, 2026Aug 14, 2026
4Aug 14, 2026Aug 14, 2026
424B5Aug 14, 2026Aug 14, 2026
SC 13D/AAug 14, 2026Aug 14, 2026

Competitors

Who does Outlook Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about OTLK's filings, answered from its disclosures.

What is the latest OTLK filing?

The latest filing shown is SC 13G dated Oct 13, 2026.

How many recent filings does OTLK have?

Intrinsic Alpha currently shows 20 recent filings for OTLK.